Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
22 studies found for:    Open Studies | "Hypoparathyroidism"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hypoparathyroidism"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in Hypoparathyroidism
Conditions: Chronic Hypoparathyroidism;   Hypoparathyroidism
Intervention: Drug: rhPTH(1-84)
2 Recruiting Survey on Epidemiology of Hypoparathyroidism in France
Condition: Hypoparathyroidism
Intervention: Other: No intervention
3 Recruiting Steroids in the Postoperative Transient Hypoparathyroidism Total Thyroidectomy
Condition: Transient Hypoparathyroidism
Interventions: Drug: phosphate and betamethasone acetate, 2 mL.;   Drug: saline 0.9% NaCl
4 Recruiting PARADIGHM A Natural History Registry for Patients With Chronic Hypoparathyroidism
Condition: Chronic Hypoparathyroidism
Intervention: Other: None [Natural history registry]
5 Recruiting Characterization of Patients With Non-surgical Hypoparathyroidism and Pseudohypoparathyroidism
Conditions: Idiopathic Hypoparathyroidism;   Autosomal Dominant Hypocalcaemia;   Pseudohypoparathyroidism
6 Recruiting Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Subjects With Hypoparathyroidism
Condition: Hypoparathyroidism
Interventions: Drug: 25mcg rhPTH(1-84);   Drug: 50mcg rhPTH(1-84);   Drug: 100mcg rhPTH(1-84)
7 Unknown  Vitamin D Levels and Postoperative Hypocalcemia After Total Thyroidectomy
Conditions: Hypocalcemia;   Hypoparathyroidism;   Vitamin D Deficiency;   Thyroidectomy
8 Recruiting Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions
Condition: 22q11.2 Deletion Syndrome
Interventions: Drug: NFC-1;   Drug: Placebo
9 Recruiting Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
Conditions: Down Syndrome;   Edwards Syndrome;   Patau Syndrome;   Klinefelter Syndrome;   Turner Syndrome;   DiGeorge Syndrome;   Chromosome Deletion;   Aneuploidy
Intervention: Other: Blood sampling for Laboratory Developed Test (LDT) analysis
10 Recruiting Non-Invasive Chromosomal Evaluation of 22q11.2
Condition: DiGeorge Syndrome, Velocardiofacial Syndrome, 22q.11.2 Deletion Syndrome
11 Recruiting Whole Blood Specimen Collection From Pregnant Subjects
Conditions: Down Syndrome;   Edwards Syndrome;   Patau Syndrome;   Klinefelter Syndrome;   Turner Syndrome;   DiGeorge Syndrome;   Perinatal Infections
Intervention: Other: Observational - no intervention
12 Recruiting SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
Conditions: 22q11 Deletion Syndrome;   DiGeorge Syndrome;   Trisomy 21;   Trisomy 18;   Trisomy 13;   Monosomy X;   Sex Chromosome Abnormalities;   Cri-du-Chat Syndrome;   Angelman Syndrome;   Prader-Willi Syndrome;   1p36 Deletion Syndrome
13 Unknown  Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.
Condition: 22q11 Deletion Syndrome
Interventions: Dietary Supplement: omega-3 PUFAs;   Other: Standard care;   Dietary Supplement: placebo
14 Recruiting Immune Disorder HSCT Protocol
Conditions: Immune Deficiency Disorders:;   Severe Combined Immunodeficiency;   Chronic Granulomatous Disease;   X-linked Agammaglobulinemia;   Wiskott-Aldrich Syndrome;   Hyper-IgM;   DiGeorge Syndrome;   Chediak-Higashi Syndrome;   Common Variable Immune Deficiency;   Immune Dysregulatory Disorder:;   Hemophagocytic Lymphohistiocytosis;   IPEX;   Autoimmune Lymphoproliferative Syndrome;   X-linked Lymphoproliferative Syndrome
Intervention: Drug: Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
15 Recruiting Thymus Transplantation Safety-Efficacy
Conditions: Complete DiGeorge Anomaly;   DiGeorge Syndrome;   DiGeorge Anomaly;   Complete DiGeorge Syndrome
Interventions: Biological: Thymus Tissue for Transplantation;   Procedure: Blood Draw;   Drug: Rabbit anti-thymocyte globulin;   Drug: Cyclosporine;   Drug: Tacrolimus;   Drug: Methylprednisolone or Prednisolone;   Drug: Basiliximab;   Drug: Mycophenolate mofetil
16 Unknown  Genetic Modifiers for 22q11.2 Syndrome
Condition: 22q11.2 Deletion Syndrome
Intervention: Other: Observation
17 Recruiting The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome
Conditions: Velocardiofacial Syndrome;   Williams Syndrome;   Fragile X Syndrome
Intervention: Drug: methylphenidate, fluoxetin, risperidone
18 Unknown  Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
Conditions: DiGeorge Syndrome;   22q11.2 Deletion Syndrome
19 Unknown  Genetics and Psychopathology in the 22q11 Deletion Syndrome
Condition: Chromosome 22q11.2 Deletion Syndrome
20 Unknown  Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome
Conditions: DiGeorge Syndrome;   Shprintzen Syndrome;   Chromosome Abnormalities;   Abnormalities, Multiple;   Conotruncal Cardiac Defects

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Indicates status has not been verified in more than two years